Banner - NPPA Connect
NP/PA Connect
News
Media
Around the PracticeBetween The LinesCase-Based Peer PerspectiveClinical Case CollectiveDermViewExpert PerspectivesFellows Face OffFrontline ForumMedical World NewsPatient PerspectivesPodcastsReadout360Recognize and Refer
Conferences
Conference CoverageConference Listing
Events
Case-Based Roundtable
More
Publication
Dermatology Times
CME/CE
Resources
DermIQInteractive ToolsJob BoardPartner PerspectivesPerspectives in DermatologyPollsSponsored ContentSponsored ResourcesSpot Test
Editorial Advisory Board
Partners

Subscribe

  • NP/PA Connect
  • News
  • Media
  • Conferences
  • Events
  • Publication
  • CME/CE
  • Resources
  • Editorial Advisory Board
  • Partners
  • Subscribe
  • Acne
  • Actinic Keratosis
  • Aesthetics
  • Alopecia
  • Artificial Intelligence
  • Atopic Dermatitis
  • Buy-and-Bill
  • COVID-19
  • Case-Based Roundtable
  • Chronic Hand Eczema
  • Chronic Spontaneous Urticaria
  • Drug Watch
  • Eczema
  • General Dermatology
  • Hidradenitis Suppurativa
  • Melasma
  • Pediatric Dermatology
  • Pigmentary Disorders
  • Practice Management
  • Precision Medicine and Biologics
  • Prurigo Nodularis
  • Psoriasis
  • Psoriatic Arthritis
  • Rare Disease
  • Rosacea
  • Skin Cancer
    • Non-Melanoma Skin Cancers
  • Vitiligo
  • Wound Care
Advertisement

Martina Porter, MD

Advertisement

Articles by Martina Porter, MD

3 Things You Should Know About HS Pathology and Management

ByPER Editorial Staff,Raj Chovatiya, MD, PhD, MSCI,Jason E. Hawkes, MD, MS,Martina Porter, MD
May 1st 2024

Earn CME credit and learn how to optimize a multimodal treatment approach for hidradenitis suppurativa.

Advertisement

Latest Updated Articles

  • 3 Things You Should Know About HS Pathology and Management
    3 Things You Should Know About HS Pathology and Management

    Published: May 1st 2024 | Updated:



Advertisement
Advertisement

Trending on Dermatology Times

1

FDA Updates iPLEDGE REMS with New Modifications for Pregnancy Testing and Prescription Windows

2

Targeting MRGPRX2: Early Human Data for a Novel CSU Approach

3

Precision Medicine Arrives in Atopic Dermatitis: Guiding Systemic Treatment Decisions Through Gene Expression Profiling

4

What Counts as “Short-Term” Systemic Corticosteroids in Atopic Dermatitis, and Why It Matters

5

Phase 3 Results Signal a New Era for Oral Targeted Therapy in Psoriasis

  • About
  • Advertise
  • Contact Us
  • Job Board
  • Do Not Sell My Information
  • Terms and Conditions
  • Privacy Policy
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us